After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Avid Bioservices Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Avid Bioservices Inc is $454.70M. A total of 0.93 million shares were traded on the day, compared to an average of 1.35M shares.
In the most recent transaction, Kwietniak Matthew R. sold 274 shares of CDMO for 6.77 per share on Jan 12 ’24. After the transaction, the Chief Commercial Officer now owns 19,829 company shares. In a previous transaction on Jan 10 ’24, Hart Daniel R sold 2,408 shares at 6.17 per share. CDMO shares that Chief Financial Officer owns now total 79,305.
Among the insiders who sold shares, Ziebell Mark R disposed of 1,346 shares on Jan 10 ’24 at a per-share price of $6.17. This resulted in the V. P., General Counsel holding 63,269 shares of CDMO after the transaction. In another insider transaction, Kwietniak Matthew R. sold 1,060 shares at $6.17 per share on Jan 10 ’24. Company shares held by the Chief Commercial Officer now total 19,434.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CDMO has a high of $21.05 and a low of $4.07.
As of this writing, CDMO has an earnings estimate of -$0.05 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.03 per share and a lower estimate of -$0.07.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CDMO’s latest balance sheet shows that the firm has $126.17M in Cash & Short Term Investments as of fiscal 2022. There were $182.53M in debt and $75.76M in liabilities at the time. Its Book Value Per Share was $2.90, while its Total Shareholder’s Equity was $174.53M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDMO is Buy with a score of 4.40.
